MDLN today
$42.16+$1.25 (+3.06%)close Nov 11, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minBearish
5 minBullish
Daily trend turns down below $31.37
Key levels
Resistance$45.67
Resistance$43.63
Support$41.60
Support$40.01
Latest news & SEC filings
AnalystUBS keeps Buy rating on Medline, lifts price target to $49
AnalystLeerink Partners keeps Medline at Outperform, lifts price target
AnalystCitigroup keeps Buy rating on Medline, lifts target to $47
All MDLN news →About Medline
Medline is a healthcare products company that makes and distributes medical supplies, including brands such as Curad, Microtek, Hudson, and Proxima. It serves hospitals, healthcare facilities, and professionals, and also sells through government healthcare programs. The company operates in the United States and internationally, including Canada, Mexico, Europe, and the Asia Pacific region, with manufacturing operations in Mexico.
Based on the company's 10-K filed Feb 25, 2026.
Nasdaq · Healthcare
Medline Inc. (MDLN)
What Is the Price Target for MDLN?
SEPT Low Target
$34.00
SEPT Mid Target
$46.00
SEPT High Target
$62.00
Analyst Consensus
$46.00
Is MDLN a Buy or Sell Right Now?
Thesis
- •Revenue growing 11.5% YoY with STABLE trend — consistent growth.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MDLN.
Start Free Trial →Is MDLN Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, Analyst Consensus
Fair Value
$41.16
32
Moat Score
NONE
6/9
Piotroski Score
2.2
Altman Z-Score
What Is Smart Money Doing with MDLN?
Insider Signal
SELLING
1 buys / 15 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| GIC Private Ltd | 10% owner | Sale | 7,816,987 | $274.8M | Oct 8, 2026 |
| GIC Private Ltd | 10% owner | Sale | 2,088,987 | $73.2M | Oct 6, 2026 |
| GIC Private Ltd | 10% owner | Sale | 7,183,013 | $251.8M | Oct 6, 2026 |
| GIC Private Ltd | 10% owner | Sale | 1,688,690 | $60.4M | Oct 5, 2026 |
| GIC Private Ltd | 10% owner | Sale | 2,570,999 | $90.9M | Oct 2, 2026 |
| GIC Private Ltd | 10% owner | Sale | 7,146,941 | $245.4M | Oct 2, 2026 |
| GIC Private Ltd | 10% owner | Sale | 100,000 | $3.6M | Aug 14, 2026 |
| GIC Private Ltd | 10% owner | Sale | 1,500,000 | $53.7M | Aug 13, 2026 |
| GIC Private Ltd | 10% owner | Sale | 590,284 | $21.0M | Aug 7, 2026 |
| Liberman Alexander M. | officer | Sale | 872 | $32K | Jun 15, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MDLN Growth Story
Revenue YoY
11.5%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
-8.3%
Revenue Trend
STABLE
Dark Pool Trades for MDLN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MDLN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:30 | $42.16 | 200,000 | $$8.4M | BUY |
| 21:00:29 | $42.16 | 2,114 | $$89K | BUY |
| 21:00:29 | $42.16 | 2,000 | $$84K | BUY |
| 21:00:29 | $42.16 | 2,537 | $$107K | BUY |
| 21:00:17 | $42.16 | 3,258 | $$137K | BUY |
5 dark pool trades shown · $$8.8M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for MDLN
PREVIEWSEPT Investing provides real-time options flow tracking for MDLN, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $42.5 | Nov 20 | 9 | $$185 | 1 | SWEEP |
| PUT | $42.5 | Nov 20 | 9 | $$2208 | 12 | SWEEP |
| PUT | $42.5 | Nov 20 | 9 | $$12.2K | 66 | SWEEP |
| PUT | $42.5 | Nov 20 | 9 | $$7400 | 40 | SWEEP |
| PUT | $42.5 | Nov 20 | 9 | $$185 | 1 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Medline Inc. (MDLN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (6 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MDLN — frequently asked questions
What is MDLN stock price today?
Medline Inc. (MDLN) is at $42.16, up 3.06% (+$1.25) at the Nov 11, 2026 close.
Why is MDLN stock moving today?
Latest MDLN news — Nov 5, 2026: UBS keeps Buy rating on Medline, lifts price target to $49 · Nov 5, 2026: Leerink Partners keeps Medline at Outperform, lifts price target
Why did MDLN stock move on Nov 4, 2026?
Medline (MDLN) shares jumped 7.97% to close at $40.35, trading between a low of $37.06 and a high of $40.80 on heavy volume of 24.76 million shares. The move followed the company's Q3 2026 earnings release, in which adjusted profit topped analyst forecasts and revenue also came in ahead of expectations.
What is the MDLN price target?
The average analyst price target for MDLN is $46.00, ranging from $34 to $62, based on 16 analysts. Latest: UBS maintains on Nov 5, 2026.
What do analysts rate MDLN?
Analyst ratings for MDLN: 0 Buy, 17 Hold, 0 Sell — consensus Hold.
Did MDLN beat earnings?
MDLN last reported on Nov 4, 2026: EPS $0.44 vs $0.34 expected — a beat of 28.2%.
Does MDLN pay a dividend?
MDLN does not currently pay a dividend.
What are MDLN support and resistance levels?
Support: $41.60, $40.01, $38.31. Resistance: $43.63, $45.67, $49.13.
What are insiders doing with MDLN?
Insider activity: SELLING, 1 buys and 15 sells in the last 90 days.
What is the latest news on MDLN?
Nov 5, 2026: UBS keeps Buy rating on Medline, lifts price target to $49 · Nov 5, 2026: Leerink Partners keeps Medline at Outperform, lifts price target · Nov 5, 2026: Citigroup keeps Buy rating on Medline, lifts target to $47